Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier
Pharmaceuticals · 19.05.2025 · 18 (5) · 751
DOI: 10.3390/ph18050751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 19.05.2025. Verfasst von Haruka Yamaguchi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Life Dentistry at Niigata, The Nippon Dental University, Niigata 951-8580, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for Promotion of Science KAKENHI, New Sustainable Growth (NSG) group.
Abstract (Originalsprache)
Near-infrared photoimmunotherapy (NIR-PIT) is a promising cancer treatment that uses near-infrared light to activate a conjugate of a monoclonal antibody (mAb) and a photoactivatable silica phthalocyanine dye (IRDye700DX: IR700). Unlike conventional photodynamic therapy (PDT), NIR-PIT selectively destroys targeted tumor cells while preserving the surrounding normal tissue and providing superior tissue penetration. Recently, NIR-PIT has been approved for the treatment of unresectable recurrent head and neck cancers in Japan. It induces highly selective cancer cell death; therefore, it is expected to be a new curative treatment option for various cancers, including brain tumors. In this review, we compare the principles of NIR-PIT and PDT and discuss the potential applications of NIR-PIT for brain tumors. We selected targetable proteins across various types of brain tumors and devised a strategy to effectively pass the mAb–IR700 conjugate through the blood–brain barrier (BBB), which is a significant challenge for NIR-PIT in treating brain tumors. Innovative approaches for delivering the mAb–IR700 conjugate across the BBB include exosomes, nanoparticle-based systems, and cell-penetrating peptides. Small-molecule compounds, such as affibodies, are anticipated to rapidly accumulate in tumors within intracranial models, and our preliminary experiments demonstrated rapid uptake. NIR-PIT also induces immunogenic cell death and activates the anti-tumor immune response. Overall, NIR-PIT is a promising approach for treating brain tumors. It has the potential to overcome the limitations of conventional therapies and offers new hope to patients with brain tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, School of Life Dentistry at Niigata, The Nippon Dental University, Niigata 951-8580, Japan.
- Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
- Department of Brain Tumor Biology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
- Near InfraRed Photo-ImmunoTherapy Research Institute, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
- Faculty of Engineering, Niigata University, Niigata 950-2181, Japan.
- Startup Incubation Center, Shimadzu Corporation, Kyoto 604-8511, Japan.
ORCID-Profile: Haruka Yamaguchi, Masayasu Okada, Jotaro On, Jun Watanabe, Yoshihiro Tsukamoto, Ryosuke Ogura, Manabu Natsumeda
Förderung
- Japan Society for the Promotion of Science
- Japan Society for Promotion of Science KAKENHI
- New Sustainable Growth (NSG) group
Zitieren
APA
Yamaguchi, H., Okada, M., Otani, T., On, J., Shibuma, S., Takino, T., Watanabe, J., Tsukamoto, Y., Ogura, R., Oishi, M., Suzuki, T., Ishikawa, A., Sakata, H., & Natsumeda, M. (2025). Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier. Pharmaceuticals, 18(5), 751. https://doi.org/10.3390/ph18050751
Vancouver
Yamaguchi H, Okada M, Otani T, On J, Shibuma S, Takino T, et al. Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier. Pharmaceuticals. 2025;18(5):751. doi:10.3390/ph18050751
BibTeX
@article{Yamaguchi2025,
author = {Yamaguchi, Haruka and Okada, Masayasu and Otani, Takuya and On, Jotaro and Shibuma, Satoshi and Takino, Toru and Watanabe, Jun and Tsukamoto, Yoshihiro and Ogura, Ryosuke and Oishi, Makoto and Suzuki, Takamasa and Ishikawa, Akihiro and Sakata, Hideyuki and Natsumeda, Manabu},
title = {Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {5},
pages = {751},
doi = {10.3390/ph18050751}
}
EUVIMED